4.7 Review

A dyadic approach to the delineation of diagnostic entities in clinical genomics

Journal

AMERICAN JOURNAL OF HUMAN GENETICS
Volume 108, Issue 1, Pages 8-15

Publisher

CELL PRESS
DOI: 10.1016/j.ajhg.2020.11.013

Keywords

-

Funding

  1. National Institutes of Health (NIH) [ZIA HG200388 06]
  2. NIH [R01 DE027879, K08NS092898]
  3. Alex's Lemonade Stand Foundation
  4. Damon Runyon Cancer Research Foundation
  5. Jordan's Guardian Angels
  6. Brotman Baty Institute

Ask authors/readers for more resources

The article proposes an approach to delineating Mendelian genetic disorders by emphasizing the relationship between genes and phenotypic descriptors, suggesting that only by considering both attributes can a distinct genetic disorder be determined.
The delineation of disease entities is complex, yet recent advances in the molecular characterization of diseases provide opportunities to designate diseases in a biologically valid manner. Here, we have formalized an approach to the delineation of Mendelian genetic disorders that encompasses two distinct but inter-related concepts: (1) the gene that is mutated and (2) the phenotypic descriptor, preferably a recognizably distinct phenotype. We assert that only by a combinatorial or dyadic approach taking both of these attributes into account can a unitary, distinct genetic disorder be designated. We propose that all Mendelian disorders should be designated as GENE-related phenotype descriptor (e.g., CFTR-related cystic fibrosis). This approach to delineating and naming disorders reconciles the complexity of gene-to-phenotype relationships in a simple and clear manner yet communicates the complexity and nuance of these relationships.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available